Physician profile
Sunitha C Alexander
NPI 1376507210
$6,397.16
in general payments reported to CMS, 2019-2025
45 companies · $1,000 in 2025
The $1,000 reported for 2025 was more than what 89% of Geriatric Medicine (Internal Medicine) providers received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,189 · 2020: $1,223 · 2021: $572 · 2022: $870 · 2023: $760 · 2024: $783 · 2025: $1,000.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,543.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,543.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $905.49 | 2021-2025 | Ubrelvy, Qulipta, Viberzi |
| Novo Nordisk INC | $656.68 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Pfizer INC. | $466.15 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $452.67 | 2020-2025 | Breztri, Airsupra, Farxiga |
| Janssen Pharmaceuticals, INC | $301.91 | 2019-2022 | |
| Lilly USA, LLC | $282.31 | 2019-2024 | Mounjaro, Zepbound |
| Sunovion Pharmaceuticals INC. | $262.44 | 2019-2021 | |
| Glaxosmithkline, LLC. | $235.61 | 2019-2025 | Trelegy Ellipta |
| Amgen INC. | $229.28 | 2019-2025 | Repatha, Otezla, Repatha |
| Dexcom, INC. | $180.88 | 2021-2025 | Dexcom G6 Transmitter |
| Amarin Pharma, INC. | $173.12 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $165.26 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $157.35 | 2019-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $155.20 | 2019-2025 | Jardiance |
| Gilead Sciences, INC. | $150.35 | 2019-2021 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sunitha Alexander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.